Literature DB >> 11986252

Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Gadi Borkow1, Zvi Bentwich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11986252      PMCID： PMC119996          DOI： 10.1128/cdli.9.3.505-507.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  44 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.

Authors:  C Stahl-Hennig; U Dittmer; T Nisslein; H Petry; E Jurkiewicz; D Fuchs; H Wachter; K Mätz-Rensing; E M Kuhn; F J Kaup; E W Rud; G Hunsmann
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

3.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

Review 4.  The global impact of HIV/AIDS.

Authors:  P Piot; M Bartos; P D Ghys; N Walker; B Schwartländer
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

5.  Immune activation, a co-factor for HIV transmission in Thailand?

Authors:  A Kalinkovich; S Maayan; Z Weisman; N Harpaz; Z Bentwich
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

6.  Cytokine patterns during the progression to AIDS.

Authors:  T R Mosmann
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

7.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

Review 9.  The immune response and immunopathology in infection with Schistosoma mansoni: a key role of major egg antigen Sm-p40.

Authors:  M J Stadecker; H J Hernandez
Journal:  Parasite Immunol       Date:  1998-05       Impact factor: 2.280

10.  Epidemiological and immunological study of HIV-seropositive Ethiopian immigrants in Israel. The Israel AIDS Study Group.

Authors:  S Pollack
Journal:  Isr J Med Sci       Date:  1993-10
View more
  5 in total

1.  Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development.

Authors:  Sandra A Koesters; Lucy Matu; Peter Kiama; Omu Anzala; Joanne Embree; Francis A Plummer; Joshua Kimani; Keith R Fowke
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

Review 2.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Chronic Schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice.

Authors:  Lin Chen; Wen-qi Liu; Jia-hui Lei; Fei Guan; Man-jun Li; Wen-jian Song; Yong-long Li; Ting Wang
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

4.  High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Authors:  Amy Y Liu; Stephen C De Rosa; Brandon L Guthrie; Robert Y Choi; Rose Kerubo-Bosire; Barbra A Richardson; James Kiarie; Carey Farquhar; Barbara Lohman-Payne
Journal:  Immun Inflamm Dis       Date:  2018-07-04

5.  Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.

Authors:  Mohammad Murshid Alam; Cassie M Jarvis; Robert Hincapie; Craig S McKay; Jiri Schimer; Carlos A Sanhueza; Ke Xu; Roger C Diehl; M G Finn; Laura L Kiessling
Journal:  ACS Nano       Date:  2020-08-17       Impact factor: 15.881
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.